| 查看: 632 | 回复: 1 | |||
[交流]
如何在药物筛选中鉴别假阳性化合物（2）——From HitGen 已有1人参与
|
|
This article describes a set of 275 rules, developed over an 18-year period, used to identify compounds that may interfere with biological assays, allowing their removal from screening sets. Reasons for rejection include reactivity (e.g., acyl halides), interference with assay measurements (fluorescence, absorbance, quenching), activities that damage proteins (oxidizers, detergents), instability (e.g., latent aldehydes), and lack of druggability (e.g., compounds lacking both oxygen and nitrogen). The structural queries were profiled for frequency of occurrence in druglike and nondruglike compound sets and were extensively reviewed by a panel of experienced medicinal chemists. As a means of profiling the rules and as a filter in its own right, an index of biological promiscuity was developed. The 584 gene targets with screening data at Lilly were assigned to 17 subfamilies, and the number of subfamilies at which a compound was active was used as a promiscuity index. For certain compounds, promiscuous activity disappeared after sample repurification, indicating interference from occult contaminants. Because this type of interference is not amenable to substructure search, a “nuisance list” was developed to flag interfering compounds that passed the substructure rules. Lilly-Medchem-Rules: Software and queries are available at https://github.com/IanAWatson/Lilly-Medchem-Rules.git Editor：qg.lai-hitgen  summary of 17 rules.png |
回复此楼» 本帖附件资源列表
-
欢迎监督和反馈：小木虫仅提供交流平台，不对该内容负责。
本内容由用户自主发布，如果其内容涉及到知识产权问题，其责任在于用户本人，如对版权有异议，请联系邮箱：xiaomuchong@tal.com - 附件 1 : Rules_for_Identifying_Potentially_Reactive_or_Promiscuous_Compounds.pdf
2016-11-30 11:29:09, 526.07 K
» 猜你喜欢
请教酰胺缩合反应
已经有6人回复
-
一志愿大连理工制药工程专硕086002，本科211，总分342
已经有0人回复
-
药物学论文润色/翻译怎么收费?
已经有226人回复
-
制药工程专业招收调剂，要求过国家线
已经有0人回复
-
五邑大学药物化学生物学团队-李兰清课题组招收调剂学生
已经有0人回复
-
求蛋白推荐，用于实验教学中蛋白药物的表达
已经有0人回复
-
求蛋白推荐，用于实验教学中蛋白药物的表达
已经有0人回复
-
求蛋白推荐，用于实验教学中蛋白药物的表达
已经有2人回复
-
342一志愿大工制药专硕，本科211，求调剂
已经有2人回复
| 谢谢分享 |
2楼2016-11-30 17:08:23
